OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 151 filers reported holding OCULAR THERAPEUTIX INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $240,000 | -29.4% | 24,000 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $340,000 | -13.7% | 24,000 | 0.0% | 0.01% | -12.5% |
| Q1 2021 | $394,000 | -20.7% | 24,000 | 0.0% | 0.01% | -27.3% |
| Q4 2020 | $497,000 | +171.6% | 24,000 | 0.0% | 0.01% | +120.0% |
| Q3 2020 | $183,000 | -8.5% | 24,000 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $200,000 | +68.1% | 24,000 | 0.0% | 0.01% | +50.0% |
| Q1 2020 | $119,000 | +25.3% | 24,000 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $95,000 | +30.1% | 24,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $73,000 | -31.1% | 24,000 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $106,000 | +11.6% | 24,000 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $95,000 | – | 24,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |